Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 20:26 | 2026-05-12 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $36.74 | 18,500 | $679,747 | 216,744 | -7.9% |
| 2026-04-15 20:57 | 2026-04-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $44.05 | 22,951 | $1,011,051 | 235,244 | -8.9% |
| 2026-02-26 03:58 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $41.98 | 16,925 | $710,578 | 257,163 | -6.2% |
| 2026-02-26 03:59 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; CHIEF FINANCIAL OFFICER | Pharmaceutical Preparations | SALE | $41.98 | 4,949 | $207,778 | 114,181 | -4.2% |
| 2026-02-26 04:00 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Young Joseph R | Officer; SVP, FINANCE, CHIEF ACCT OFFCR | Pharmaceutical Preparations | SALE | $41.98 | 3,117 | $130,864 | 64,722 | -4.6% |
| 2026-02-26 04:01 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Brenner Robert | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $41.98 | 2,151 | $90,307 | 50,947 | -4.1% |
| 2026-02-26 03:53 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Skelton Laurence Matthew | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $41.98 | 1,582 | $66,419 | 64,218 | -2.4% |
| 2026-02-26 03:56 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | SALE | $41.98 | 2,187 | $91,819 | 45,313 | -4.6% |
| 2026-02-26 03:57 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | JOHNSON DAVID LEE | Officer; Chief Operating Officer | Pharmaceutical Preparations | SALE | $41.98 | 2,579 | $108,276 | 45,727 | -5.3% |
| 2025-12-18 00:05 | 2025-12-15 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | OPT+S | $50.08 | 10,000 | $500,767 | 22,500 | -30.8% |
| 2025-12-16 04:07 | 2025-12-11 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $42.50 | 5,882 | $249,985 | 5,882 | +100.0% |
| 2025-12-11 00:05 | 2025-12-08 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | OPT+S | $45.31 | 10,000 | $453,053 | 22,500 | -30.8% |
| 2025-12-05 00:05 | 2025-12-03 | VERA | Vera Therapeutics, Inc. | Turner William D. | Officer; Chief Regulatory Officer | Pharmaceutical Preparations | OPT+S | $40.00 | 10,000 | $400,000 | 22,500 | -30.8% |
| 2025-11-26 00:05 | 2025-11-21 | VERA | Vera Therapeutics, Inc. | Carter Jason S | Officer; Chief Legal Officer | Pharmaceutical Preparations | SALE | $27.82 | 3,864 | $107,498 | 49,136 | -7.3% |
| 2025-11-14 04:57 | 2025-11-11 | VERA | Vera Therapeutics, Inc. | Young Joseph R | Officer; SVP, FINANCE, CHIEF ACCT OFFCR | Pharmaceutical Preparations | OPT+S | $29.06 | 15,000 | $435,875 | 47,839 | -23.9% |
| 2025-06-26 03:07 | 2025-06-23 | VERA | Vera Therapeutics, Inc. | ENRIGHT PATRICK G | Director | Pharmaceutical Preparations | BUY | $21.11 | 250,000 | $5,277,300 | 3,596,593 | +7.5% |
| 2025-02-28 00:05 | 2025-02-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $27.78 | 19,688 | $546,913 | 204,665 | -8.8% |
| 2025-01-11 00:06 | 2025-01-08 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $41.74 | 17,500 | $730,536 | 143,603 | -10.9% |
| 2024-12-21 00:06 | 2024-12-18 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $43.07 | 17,500 | $753,680 | 85,942 | -16.9% |
| 2024-12-14 00:07 | 2024-12-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $46.94 | 17,500 | $821,524 | 85,942 | -16.9% |
| 2024-11-28 00:05 | 2024-11-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $47.98 | 19,375 | $929,560 | 85,942 | -18.4% |
| 2024-11-16 00:05 | 2024-11-13 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $49.50 | 30,625 | $1,516,039 | 85,942 | -26.3% |
| 2024-10-30 23:06 | 2024-10-28 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | SALE | $48.03 | 15,000 | $720,494 | 131,553 | -10.2% |
| 2024-10-25 23:04 | 2024-10-23 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $40.39 | 19,375 | $782,611 | 307,972 | -5.9% |
| 2024-10-11 23:05 | 2024-10-09 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $38.24 | 15,625 | $597,569 | 307,972 | -4.8% |
| 2024-09-27 23:05 | 2024-09-25 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $46.05 | 23,125 | $1,064,809 | 307,972 | -7.0% |
| 2024-09-20 23:45 | 2024-09-18 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | SALE | $42.26 | 16,476 | $696,233 | 146,553 | -10.1% |
| 2024-09-13 23:36 | 2024-09-11 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $37.50 | 15,625 | $585,934 | 307,972 | -4.8% |
| 2024-08-30 23:04 | 2024-08-28 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $36.85 | 30,320 | $1,117,140 | 307,972 | -9.0% |
| 2024-08-24 00:40 | 2024-08-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | SALE | $39.76 | 14,471 | $575,425 | 322,667 | -4.3% |
| 2024-08-16 23:31 | 2024-08-14 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; PRESIDENT AND CEO | Pharmaceutical Preparations | OPT+S | $37.56 | 15,625 | $586,927 | 337,138 | -4.4% |
| 2024-05-17 23:21 | 2024-05-15 | VERA | Vera Therapeutics, Inc. | Young Joseph R | Officer; SVP, FINANCE, CHIEF ACCT OFFCR | Pharmaceutical Preparations | OPT+S | $42.30 | 30,837 | $1,304,436 | 51,206 | -37.6% |
| 2024-04-12 23:02 | 2024-04-10 | VERA | Vera Therapeutics, Inc. | Young Joseph R | Officer; SVP, FINANCE, CHIEF ACCT OFFCR | Pharmaceutical Preparations | SALE | $40.00 | 5,714 | $228,560 | 53,171 | -9.7% |
| 2024-04-06 04:32 | 2024-04-03 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; CHIEF FINANCIAL OFFICER | Pharmaceutical Preparations | OPT+S | $39.58 | 118,477 | $4,689,722 | 5,000 | -96.0% |
| 2024-03-26 04:46 | 2024-03-21 | VERA | Vera Therapeutics, Inc. | Katabi Maha | Director | Pharmaceutical Preparations | SALE | $40.86 | 834,459 | $34,099,583 | 2,793,987 | -23.0% |
| 2024-02-02 01:58 | 2024-01-30 | VERA | Vera Therapeutics, Inc. | Katabi Maha | Director | Pharmaceutical Preparations | BUY | $31.00 | 161,290 | $4,999,990 | 3,628,446 | +4.7% |
| 2024-01-13 05:55 | 2024-01-10 | VERA | Vera Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% owner | Pharmaceutical Preparations | SALE | $18.00 | 1,050,000 | $18,900,000 | 4,400,000 | -19.3% |
| 2023-08-24 00:59 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Lin Celia | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $16.65 | 1,490 | $24,816 | 11,010 | -11.9% |
| 2023-08-24 00:57 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Curley Joanne | Officer; Chief Development Officer | Pharmaceutical Preparations | SALE | $16.66 | 1,490 | $24,817 | 26,962 | -5.2% |
| 2023-08-24 00:56 | 2023-08-21 | VERA | Vera Therapeutics, Inc. | Fordyce Marshall | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $16.66 | 5,210 | $86,779 | 243,361 | -2.1% |
| 2023-06-23 23:05 | 2023-06-23 | VERA | Vera Therapeutics, Inc. | Grant Sean | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $16.60 | 5,000 | $83,000 | 5,992 | +504.0% |
| 2023-06-22 23:10 | 2023-06-20 | VERA | Vera Therapeutics, Inc. | COMMODORE CAPITAL LP | 10% owner | Pharmaceutical Preparations | BUY | $15.17 | 448,217 | $6,799,004 | 5,450,000 | +9.0% |
| 2023-04-03 23:05 | 2023-03-30 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 2,300 | $16,651 | 1,949,295 | +0.1% |
| 2023-03-30 23:07 | 2023-03-28 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 23,908 | $173,192 | 1,946,995 | +1.2% |
| 2023-03-28 23:05 | 2023-03-24 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 3,466 | $25,102 | 1,923,087 | +0.2% |
| 2023-03-21 23:40 | 2023-03-17 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.13 | 89,297 | $636,911 | 1,919,621 | +4.9% |
| 2023-03-17 23:10 | 2023-03-15 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.10 | 92,941 | $660,281 | 1,830,324 | +5.3% |
| 2023-03-14 23:05 | 2023-03-10 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.16 | 48,003 | $343,485 | 1,737,383 | +2.8% |
| 2023-03-08 00:07 | 2023-03-03 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.25 | 1,000 | $7,245 | 1,689,380 | +0.1% |
| 2023-03-04 00:07 | 2023-03-01 | VERA | Vera Therapeutics, Inc. | SEIDENBERG BETH C | Director | Pharmaceutical Preparations | BUY | $7.24 | 23,478 | $170,046 | 1,688,380 | +1.4% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.